News Feed

Dr. Lisa Marsch testifies at House Bipartisan Heroin Task Force on NH fentanyl overdose crisis

On Monday, February 6, Dr. Lisa Marsch, Director of the Northeast Node and the Center for Technology and Behavioral Health (CTBH), testified at a Congressional briefing of the House Bipartisan Heroin Task Force.


Node study featured in Union Leader

The Northeast Node’s Phase 2 Fentanyl Hot Spot study, Understanding Opioid Overdoses in New Hampshire, was recently featured in the Union Leader. The article explains New Hampshire’s fentanyl-related overdose crisis and how the study aims to answer the question: Why does New Hampshire have such a big problem? You can read the full article here.


The Voice of New Hampshire’s Young Adults report outlines perspectives on substance misuse

The New Hampshire Bureau of Drug and Alcohol Services (BDAS) Prevention and Education Services recently completed an extensive study that interviewed 366 young adults in New Hampshire and asked them about their attitudes and perceptions of substance misuse in New Hampshire.


Northeast Node co-sponsors Koop symposium on behavioral health stigma

The Northeast Node of the National Drug Abuse Treatment Clinical Trials Network co-sponsored the Dartmouth College 10th annual C. Everett Koop Symposium on Addiction Medicine, Thursday, December 8, 2016. This year’s symposium, “Reducing Behavioral Health Stigma in Healthcare Systems and Communities,” featured speakers from various settings that encounter behavioral health stigma in their daily activities.


Drug Reports for Maine, New Hampshire, and Vermont

Each of our partnering states releases reports that compile data on their individual opioid and overdose crises. For information on each state’s individual reports, see below.


Maine’s report is released annually by the Maine Department of Health and Human Services. The 2015 Substance Abuse Trends in Maine – State Epidemiological Profile can be found here, and with previous reports on the DHHS website.

New Hampshire

New Hampshire’s report is released monthly by the New Hampshire Bureau of Drug and Alcohol Services (BDAS) Drug Monitoring Initiative. Monthly reports can be found on the BDAS website.


Vermont’s report is released in multiple formats and can be found on the Vermont Department of Health website. A presentation report is assembled in October, which can be found here.


NH releases Drug Monitoring Initiative report for September 2016

The New Hampshire Drug Monitoring Initiative (DMI) has released its September 2016 Drug Environment Report. This report is cumulative of both past year data as well as annual measures that go back as far as 2010.

The Department of Health and Human Services (DHHS)-sponsored DMI is “a holistic strategy to provide awareness and combat drug distribution and misuse.” The DMI collects and reports on drug data from sources in New Hampshire such as public health, law enforcement, emergency medical services, Safe Station, and state emergency departments to name a few.

The September DMI report is available to view below, and is also available on the DHHS website. Previous monthly DMI reports can also be found on the DHHS website.


AutoSense cocaine detection study highlighted in Geisel Insider e-Magazine

A Northeast Node sponsored project, “Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network,” also known as AutoSense, was recently highlighted by the Geisel Insider, Dartmouth Medical School’s e-magazine.

The study, which is being done in collaboration with colleagues Dr. Santosh Kumar (Memphis University, Mobile Sensor Data-to-Knowledge Center of Excellence), Dr. Emre Ertin (Ohio State University), Dr. Kenzie Preston (NIDA Intramural Research Program), and Dr. August Holtyn (Johns Hopkins University), will develop a wrist-worn sensor that can detect in-the-moment cocaine use via interbeat heart rate. You can learn more about the study’s specific aims here.

You can read the full article published in the Geisel Insider here.

Node awarded Phase 2 of New Hampshire Fentanyl HotSpot Study

In partnership with the National Drug Early Warning System (NDEWS), the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN) has been awarded funds to complete the second phase of the Fentanyl Hot Spot Study conducted in New Hampshire earlier this summer.


Node Involved in National Research Study

The CTN Northeast Node, alongside its partners, is participating in a nation-wide study of electronic health records (EHR) available throughout the CTN.


Node participating in NDEWS ‘Hot Spot’ study of New Hampshire fentanyl use

The CTN Northeast Node is pleased to announce our participation in a National Drug Early Warning Systems (NDEWS) “Hot Spot” study. NDEWS is a NIDA-funded cooperative agreement with the University of Maryland’s Center for Substance Abuse Research (CESAR).